期刊文献+

循环肿瘤细胞在乳腺癌中的应用研究进展 被引量:5

The Advances of Application of Circulating Tumor Cells in Breast Cancer
原文传递
导出
摘要 目的总结循环肿瘤细胞在乳腺癌诊治中的应用研究进展。方法采用文献复习的方法,对乳腺癌循环肿瘤细胞在乳腺癌中的应用研究进展的相关文献加以综述。结果对早期乳腺癌患者,循环肿瘤细胞检测可发现高危复发和转移人群;对复发转移性乳腺癌患者,循环肿瘤细胞检测可以评估辅助化疗的疗效及患者的预后。探究循环肿瘤细胞的分子特征有助于了解肿瘤的转移机理及寻找新的治疗靶点。结论循环肿瘤细胞在乳腺癌的治疗中具有重要作用,但将其应用于临床尚需多中心、大型前瞻性临床研究论证。 Objective To summary the advance of circulating tumor cells in breast cancer. Methods Through reviewing the related studies,a series of clinical studies on advance of circulating tumor cells in breast cancer were reviewed. Results For early breast cancer patients,the detection of circulating tumor cells could find patients at high risk of recurrence and metastasis. For metastatic breast cancer patients,it could assess the efficacy of adjuvant chemotherapy and predict the prognosis. To explore the molecular characteristics of circulating tumor cells could help to understand tumor transfer mechanism and seek new therapeutic targets. Conclusion Circulating tumor cells play an important role in the treatment of breast cancer,but many multi-center prospective studies are needed to ensure whether circulating tumor cells can be used in clinical practice.
出处 《中国普外基础与临床杂志》 CAS 2014年第9期1167-1172,共6页 Chinese Journal of Bases and Clinics In General Surgery
基金 新疆维吾尔自治区自然科学基金(项目编号:2011211A084)~~
关键词 循环肿瘤细胞 乳腺癌 综述 Circulating tumor cells Breast cancer Review
  • 相关文献

参考文献68

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013,63(1) : 11-30.
  • 2Alix-Panabieres C, Pantel K. Circulating tumor cells: liquid biopsy of cancer [J]. Clin Chem, 2013,59(1): 110-118.
  • 3Reid AH, Attard G, Danila DC, et al. Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate [J]. J Clin Oncol, 2010, 28(9): 1489-1495.
  • 4Hayashi N, Nakamura S, Tokuda Y, et al. Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer [J]. Int J Clin Oncol, 2012, 17(2): 96-104.
  • 5Liska V, Holubec L, Treska V, et al. Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer [J]. Anticancer Res, 2011,31(4): 1447-1451.
  • 6De Giorgi U, Valero V, Rohren E, et al. Circulating tumor cells and [ 18F ] fluorodeoxyglucose positron emission tomography/ computed tomography for outcome prediction in metastatic breast cancer [J]. J Clin Oncol, 2009, 27(20): 3303-3311.
  • 7Graves H, Czerniecki BJ. Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression [J]. Patholog Res Int, 2011,2011 : 621090.
  • 8Langley RR, Fidler IJ. The seed and soil hypothesis revisited-- the role of tumor-stroma interactions in metastasis to different organs [J]. Int J Cancer, 2011, 128(11): 2527-2535.
  • 9Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death [J]. Aust Med J, 1986, 14: 146-149.
  • 10钱六七(综述),江泽飞(审校).乳腺癌血清肿瘤标志物和循环肿瘤细胞检测的研究进展[J].肿瘤研究与临床,2012,24(12):852-855. 被引量:6

二级参考文献29

  • 1王玉栋,刘巍.肿瘤标志物与乳腺癌骨转移的诊治[J].肿瘤研究与临床,2006,18(4):283-286. 被引量:6
  • 2Liska V, Holubec L Jr, Treska V, et al. Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer. Anticancer Res. 2011.31: 1447-1452.
  • 3Duffy MJ, Evoy D, McDermott EW, et al. CA 15-3: uses and limitation as a biomarker for breast cancer.Clin Chim Acta,2010,411:1869- 1874.
  • 4Wn SC, Chou FF, Rau KM, et al. Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. Breast Cancer Res Tr, 2010, 124: 879-882.
  • 5Yerushalmi R, Tyldesley S, Kennecke H, et al. Tumor markers inmetastatic breast cancer subtypes: frequency of elevation and correlation with outcome. Ann Oncol, 2012, 23: 338-345.
  • 6Nicolini A, Tartarelli G, Carpi A ,et al. Intensive post-operative follow- up of breast cancer patients with tumour markers: CEA, TPA or CA15. 3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. BMC Cancer, 2006, 6: 269.
  • 7Berruti A, Tampellini M, Torta MI et al. Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur J Cancer, 1994, 30: 2082-2084.
  • 8Molina R, Auge JM, Escudero JM, et al. Evaluation of tumor markers (HER-2/neu oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer: prognostic value. Tumour Biol, 2010, 31: 171-150.
  • 9Molina R, Auge JM, Farms B, et al. Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer. Clin Chem, 2010, 56: 1148-1157.
  • 10Sandri MT, Salvatici M, Botteri E, et al. Prognostic role of CA15.3 in 7942 patients with operable breast cancer. Breast Cancer Res Tr, 2011, 132: 317-326.

共引文献5

同被引文献65

  • 1鲍建勋,王号飞,黄云娟.人参皂苷Rg3联合奥沙利铂和索拉非尼对肝癌细胞凋亡的影响[J].中国生化药物杂志,2014,34(1):41-42. 被引量:8
  • 2任讯.乳腺癌发病率居我国城市女性肿瘤首位[N].中国医药报,2010-02-04(A04):1.
  • 3Ashwoah TR.A case of cancer in which cells similar to those in the tumors were seen in the blood after death [ J].Aust Med J, 1869, 14:146-149.
  • 4Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2015 [ J]. CA: Cancer J Clin,2015,65( 1 ) :5-29.DOI: 10.3322/caac.21254.
  • 5Serrano MJ, Sanchez Rovira P, Martinez-Zuhiaurre I, et al. Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy [ J] .Exp Ther Med, 2012,4( 1 ) :43-48.DOI: 10.3892/etm.2012. 540.
  • 6Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor ceils exhibit dynamic changes in epithelial and mesenchymal composition [ J]. Science, 2013, 339 ( 6119 ) : 580-584. DOI: 10. 1126/science. 1228522.
  • 7Mostert B, Sleijfer S, Foekens JA, et al. Circulating tumor cells (CTC) : detection methods and their clinical relevance in breast cancer [ J ]. Cancer Treat Rev, 2009,35 ( 5 ) : 463-474. DOI : 10. 1016/i.ctrv.2009.03.004.
  • 8Broersen LHA, van Pelt GW, Tollenaar RAEM, et al. Clinical application of circulating tumor cells in breast cancer [J]. Cell Onco1,2014,37 ( 1 ) :9-15.DOI : 10.1007/s13402-013-0160-6.
  • 9Cohen SJ, Punt CJA, Iannotti N, et al. Relationship of circulating tumor cells to tumor response,progression-free survival,and overall survival in patients with metastatic colorectal cancer [J].J Clin Onco1,2008,26(19) :3123-3213.DOI : 10.1200/JC0.2009.22.9419.
  • 10Pachmann K, Clement JH, Schneider CP, et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer [ J]. Clin Chem Lab Med, 2005,43 (6) : 617-627. DOI: 10.1515/CCLM.2005. 107.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部